Agios Pharmaceuticals Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $56 From $60
Agios製藥公司:Leerink合作伙伴將評級從表現優異降至市場表現;將目標價從$60削減至$56
Agios Pharmaceuticals Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $56 From $60
Agios製藥公司:Leerink合作伙伴將評級從表現優異降至市場表現;將目標價從$60削減至$56
譯文內容由第三人軟體翻譯。